Bimatoprost-Mepha Plus

Bimatoprost-Mepha Plus is a medicine authorised by Swissmedic under authorisation number 66976. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 October 2018 and the authorisation is limited until 01 January 2027. ATC code S01ED51 places the medicine in the group Ophthalmologicals.

  • Dispensing category B
  • Authorisation number 66976
  • ATC S01ED51
  • Synthetic medicines
Authorisation data
Authorisation number66976
NameBimatoprost-Mepha Plus
Full nameBimatoprost-Mepha Plus, Augentropfen
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeS01ED51
First authorisation03 October 2018
Authorisation validity01 January 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Bimatoprost-Mepha Plus, AugentropfenB03 October 2018

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
13mlS01ED5111.09.0.B
23 x 3mlS01ED5111.09.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Bimatoprost-Mepha Plus authorised in Switzerland?

Yes. Bimatoprost-Mepha Plus is authorised by Swissmedic under authorisation number 66976, data as of 01 September 2026. The authorisation is limited until 01 January 2027.

Which dispensing category does Bimatoprost-Mepha Plus have?

Bimatoprost-Mepha Plus is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Bimatoprost-Mepha Plus?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com